The US Food and Drug Administration is expected to authorize the Pfizer Inc and BioNTech SE coronavirus vaccine for children aged 5 to 11 years on Friday, the New York Times reported, citing people familiar with the agency's planning.
The agency's decision will make it the first COVID-19 shot for young children in the United States.
The decision is expected to make the vaccine available to 28 million children - many of whom are back in school for in-person learning - in the coming days. It comes after a panel of advisers to the FDA voted overwhelmingly to recommend the authorization on Tuesday.